CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Exicure Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Exicure Inc
2430 N. HALSTED ST.
Phone: (847) 673-1700p:847 673-1700 CHICAGO, IL  60614  United States Ticker: XCURXCUR
Business Summary
Exicure, Inc. is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The Company, through GPCR Therapeutics USA Inc. (GPCR USA), is focused on developing and commercializing an intellectual property and patents related to G-Protein Coupled Receptors. GPCR USA is conducting a Phase II clinical trial for a blood cancer treatment involving GPC-100 (Burixafor). The Company is also exploring strategic alternatives to maximize stockholder value.
(Source: 10KSB40)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023YesYes---

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Director AndyYoo 45 12/17/2024 11/21/2024
President, Secretary, CEO, CFO & Director IanJacobs
Chief Financial Officer, Company Secretary, Director Seung IkBaik 39 12/19/2024 11/21/2024
8 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
GPCR Therapeutics USA Inc. 400 Seaport Ct. Redwood City CA United States

Business Names
Business Name
EXCR
Exicure Operating Company
GPCR Therapeutics USA Inc.
XCUR

General Information
Number of Employees: 6 (As of 9/30/2024)
Outstanding Shares: 2,605,701 (As of 11/26/2024)
Shareholders: 65
Stock Exchange: NASD
Federal Tax Id: 815333008
Fax Number: (847) 556-6411


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, January 29, 2025